Skip to main content
PLOS One logoLink to PLOS One
. 2024 Sep 5;19(9):e0308389. doi: 10.1371/journal.pone.0308389

Inositol trisphosphate and ryanodine receptor signaling distinctly regulate neurite pathfinding in response to engineered micropatterned surfaces

Joseph T Vecchi 1,2, Madeline Rhomberg 2, C Allan Guymon 3, Marlan R Hansen 1,2,*
Editor: Sujeong Jang4
PMCID: PMC11376539  PMID: 39236043

Abstract

Micro and nanoscale patterning of surface features and biochemical cues have emerged as tools to precisely direct neurite growth into close proximity with next generation neural prosthesis electrodes. Biophysical cues can exert greater influence on neurite pathfinding compared to the more well studied biochemical cues; yet the signaling events underlying the ability of growth cones to respond to these microfeatures remain obscure. Intracellular Ca2+ signaling plays a critical role in how a growth cone senses and grows in response to various cues (biophysical features, repulsive peptides, chemo-attractive gradients). Here, we investigate the role of inositol triphosphate (IP3) and ryanodine-sensitive receptor (RyR) signaling as sensory neurons (spiral ganglion neurons, SGNs, and dorsal root ganglion neurons, DRGNs) pathfind in response to micropatterned substrates of varied geometries. We find that IP3 and RyR signaling act in the growth cone as they navigate biophysical cues and enable proper guidance to biophysical, chemo-permissive, and chemo-repulsive micropatterns. In response to complex micropatterned geometries, RyR signaling appears to halt growth in response to both topographical features and chemo-repulsive cues. IP3 signaling appears to play a more complex role, as growth cones appear to sense the microfeatures in the presence of xestospongin C but are unable to coordinate turning in response to them. Overall, key Ca2+ signaling elements, IP3 and RyR, are found to be essential for SGNs to pathfind in response to engineered biophysical and biochemical cues. These findings inform efforts to precisely guide neurite regeneration for improved neural prosthesis function, including cochlear implants.

Introduction

The intricate process of neurite growth and guidance is fundamental for the establishment of functional neuronal circuits, both during neurodevelopment and in regenerative processes. The precise targeting of axons and dendrites is determined by the growth cone integrating and responding to diverse biochemical and biophysical gradients and borders as it is pathfinding [1, 2]. Studying this process is essential to understand neural development as well as to engineer de novo neurite growth towards desired targets such as neural electrodes. Precisely directing neurite growth towards stimulating or recording electrodes has the potential to significantly enhance the performance of neural prosthetics [3, 4]. In response to these goals, crafting specific patterns of guidance cues to precisely direct neurite growth has been an active area of research [5, 6].

Recent advancements have introduced micro and nanoscale biochemical and topographical features as tools to influence neurite growth and neural circuitry [7, 8]. In this, the growth cone plays a pivotal role in pathfinding by responding to diverse environmental signals, including biochemical gradients, matrix proteins, and biophysical cues. Understanding how the growth cone integrates these cues is crucial for enhancing neural-biomaterial interactions and designing effective neural prosthetics. The role of Ca2+ signaling in growth cone guidance has been well-established, with localized concentration gradients generated within the growth cone to orchestrate turning responses [9, 10]. Interestingly, recent evidence suggests that the intracellular signaling mechanisms which govern neurite guidance in response to biochemical cues also play a role in topographical neurite guidance [11, 12]. However, the mechanisms through which growth cones transduce biophysical cues into directed neurite growth, and if these mechanisms are generally recruited in response to other cues, remain largely unexplored.

Spiral ganglion neurons (SGNs), the target neurons of cochlear implants, offer a valuable model for studying neurite alignment and turning in response to biophysical and biochemical cues. Studying these neurons is important since stimulation and precise guidance of neurite outgrowth into close proximity stands to enhance the functionality of next generation cochlear implants (CIs). In SGNs and other sensory neurons, the importance of Ca2+ signaling, and inositol triphosphate (IP3) and ryanodine receptors (RyR) in particular, for pathfinding has been established [13, 14]. Multiple studies demonstrate contribution of IP3 signaling in growth cone steering, especially in turning in response to chemo-attractive cues [1517] while the role of RyR signaling appears more complex [18]. RyR signaling does not appear to contribute to turning behavior in response to chemo-attractive cues [15], but is necessary for neurite alignment to biophysical cues [17] and may be involved in regenerative outgrowth or degeneration in certain contexts [1921].

Therefore, while intracellular Ca2+ signaling events have been implicated in neurite guidance, integrating these findings into a comprehensive model of neurite pathfinding in response to various cues is needed. Neurite pathfinding represents a multi-step process, wherein a growth cone must effectively perceive cues of different types (soluble biochemical, substrate proteins, biophysical), synthesize and integrate the signals, and subsequently execute an appropriate behavioral response (repulsion, turning, growth). It is clear that both IP3 and RyR signaling are involved in neurite pathfinding, however, further investigation is warranted to elucidate the general role intracellular Ca2+ signals play in governing how a growth cone responds to diverse cue types and geometries. In particular, focus should be given to the specific aspects (repulsion, turning, growth) of neurite pathfinding that these signaling pathways regulate as well as the specific growth cues which activate IP3R and RyR. Consequently, this study seeks to establish parallels between the intracellular signaling events that are triggered by biochemical and topographical cues, therefore aiming to identify master regulators that underlie the complex processes of neurite sensing and pathfinding in response to growth cues.

To investigate the intricate processes of neurite growth, guidance, and signal transduction across various guidance cues, we engineered various, novel micropatterned surfaces and analyzed the role of intracellular Ca2+ signals on neurite pathfinding in response to the diverse cues using targeted pharmacologic inhibitors. These engineered substrates include three different topographically micropatterned systems and two biochemically patterned surfaces. The substrates all consist of stable growth cues and represent a wide array of cues presented to the growing neurite. In particular, we engineer the substrates to consist of cues ranging from, chemo-permissive, chemo-repulsive, repeating linear topographies, repeating multidirectional topographies, and topographical turn challenges. In studying neurite growth in response to these substrates, we find that IP3 and RyR signaling each contribute to growth cone responses to these varied biophysical and biochemical cues, however in distinct ways, suggesting generalized mechanisms regulating neurite pathfinding. Our findings inform fundamental processes governing neural regeneration as well as the design of advanced neural prosthetics that can integrate with target neural tissues to more accurately recapitulate the intimate circuitry of the native nervous system.

Methods

Animals

All procedures involving animals were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the University of Iowa Institutional Animal Care and Use Committee via written consent of the protocol, #1101569. All mice were maintained on a C57BL/6 (Envigo) background and housed in groups on a standard 12:12 h light: dark cycle with food and water provided ad libitum. Mice were sacrificed for experimental use at p3-5 of age without anesthesia via rapid decapitation with sharp scissors. This method was chosen to rapidly sacrifice the animals and minimize neural damage. Importantly, SGN peripheral processes already contact hair cells in the organ of Corti at age p3-5. For the live cell imaging, neurons were harvested from Pirt-GCaMP3 transgenic mice gifted from Dr. Xinzhong Dong of John Hopkins University [22].

Micropatterned topographical substrates

Topographically micropatterned substrates were generated as previously described using photopolymerization [23]. First, a monomer solution was made consisting of 40 wt% hexyl methacrylate (HMA, Aldrich), 59 wt% 1,6-hexanediol dimethacrylate (HDDMA, Aldrich), and 1 wt% of 2,2-dimethoxy-2-phenylacetophenone (DMPA, BASF). Then, to create the patterned substrates, this solution was evenly dispersed on a silane-coupled piece of cover glass by placing the glass-chrome custom photomask (Applied Image Inc.) on top. These samples were then exposed to 365 nm light at an intensity of 16mW/cm2 using a high-pressure mercury vapor arc lamp (Omnicure S1500, Lumen Dynamics, Ontario, Canada) to polymerize the monomer solution. The opaque portions mask areas of monomer from UV radiation thereby modulating the rate of the polymerization locally to generate features on the surface. The mask induced light modulation creates differential polymerization regions with raised features or ridges underneath transparent bands where UV light intensity and the polymerization rate are highest. These substrates direct the growth of various cells and neurons, including SGNs and DRGNs [24]. Additionally, various geometries of topographical substrates can be generated by varying the photomask [25] or UV light exposure (to change feature amplitude) [23]. In such, here we utilize 3 different geometries for the micropatterned features. First a pattern of narrow repeating rows of ridges and grooves with a periodicity of 10 μm and amplitude of 3 μm [26]. Second is a pattern of repeating 90° zigzags with a periodicity of 50 μm and amplitude of 4 μm [25]. Lastly, we created a novel system with 6 different patterned turn challenges, ranging from 30 to 180 (straight) degrees, where the width of the microfeature groove is 20 μm and amplitude is 4 μm.

The dimensions and characteristics of every substrate used in the following experiments was measured using white light interferometry (Dektak Wyko 1100 Optical Profiling System, Veeco) [23]. Feature amplitude was characterized in 5 regions of the glass coverslip and neurons were only cultured on areas within +/- 10% of the target microfeature amplitude.

Creation of chemo-permissive laminin stripe pattern

Unpatterned HDDMA/HMA substrates were biochemically patterned with laminin stripes as previously described [27]. Briefly, a solution of laminin (40μg/ml, Sigma-Aldrich) with 0.05 wt % 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone (HEPK, Ciba), a photoradical generator, was pipetted onto these acrylate substrates. A photomask with repeating 25μm stripes and clear bands was placed on the substrate to evenly distribute the liquid. The sample was illuminated for 50 s with UV-light using a mercury vapor arc lamp (Omnicure S1500) at intensity of 16 mW/cm2 as measured at 365 nm to denature and deactivate the protein exposed to light. The photomask was then removed and the surface was washed once with PBS(-/-) and stored in PBS(-/-) until use.

Creation of chemo-repulsive EphA4-Fc stripe pattern

Unpatterned HDDMA/HMA substrates were biochemically patterned with EphA4-Fc stripes on a uniform laminin coating as previously described [28]. First, substrates were uniformly coated by evenly distributing a laminin solution (20μg/ml, Sigma-Aldrich) overnight at 4°C. Next, a topographical micropattern with alternating ridges and troughs defined by a periodicity of 50 μm and amplitude of 2 μm was uniformly coated with EphA4-Fc (10 μg/ml, R&D Systems) for 1 h to create a peptide “stamp”. After removing the excess solution from both the stamp and the laminin substrate, the stamp was firmly pressed onto the laminin substrate to create the EphA4-Fc stripe pattern.

Immunofluorescent labeling was incorporated in each experiment to confirm the presence of the peptide pattern. For this, primary and secondary antibodies were added to the labeling procedure as described in more detail in the section “Comparing rDRGN growth cone morphology on micropatterned substrate” below. Specifically, anti-laminin rabbit polyclonal antibody (1:500, Abcam) was added followed by Alexa 633 conjugated secondary antibody (1:800, ThermoFisher). Since EphA4-Fc is a chimeric peptide, only labeling with Alexa 488 conjugated anti-human IgG antibody (1:800, ThermoFisher) is required to detect and label the Fc portion of the peptide. EphA4-Fc functions as a repulsive growth cue to SGN neurites [2832].

Replated dorsal root ganglion neuron cultures

DRGNs were isolated as previously described, [33] however, using neonatal (p3-p5) mice. First, a 24-well polystyrene plate was coated with poly-L-ornithine solution (Sigma-Aldrich) for 1 h at RT. The surface was washed with sterile Milli-Q® three times prior to a laminin solution (20 μg/ml, Sigma-Aldrich) being applied and incubated overnight at 4°C. After warming the coated well plate for 1 h at 37°C, the freshly dissected DRGNs were cultured on this plate for 72 h before being replated. The replating procedure has been described previously, [34] but after a 1 min incubation with TrypLE Express (Thermo Fisher), warm media was used to gently triturate the culture surface and lift the adhered neurons. The resulting replated DRGNs (rDRGNs) were then cultured on the micropatterned or unpatterned HDDMA/HMA substrates in a humidified incubator with 6% CO2. Each experiment using rDRGNs was repeated three times, where each experimental replicate was conducted utilizing a pool of DRGs from the lumbar region of one mouse.

Spiral ganglion neuron cultures

The day before the biochemical patterning and culture, substrates were sterilized by soaking in 70% ethanol for 2 min and then exposure to UV light in a cell culture hood for 15 min. After creating the biochemical patterns of interest cloning cylinders were placed on the patterned coverslips. SGN cultures were prepared from mice between post-natal day 3 and 5 (p3-p5). Mice were decapitated, and their cochleae were isolated from their temporal bones in ice-cold PBS. Then the spiral ganglia were isolated and placed into ice-cold HBSS(-/-) as previously described. [35] Enzymatic dissociation was then performed in calcium- and magnesium-free HBSS with 0.1% collagenase and 0.125% trypsin at 37°C for 25 min. 100 μL of FBS was added to stop dissociation. Ganglia were washed with Neurobasal media before placing in supplemented Neurobasal Medium (Thermo Fisher) containing: 5% FBS, 2% N2 Supplement (Thermo Fisher), 10 μg/mL Insulin, 50 ng/mL BDNF (R&D Systems), and 50 ng/mL NT-3 (Sigma-Aldrich). Once in supplemented media, ganglia were triturated first with a 1000 μL pipette tip followed by a 200 μL tip. Cultures were plated onto micropatterned substrates and maintained in a humidified incubator with 6% CO2 for 48 h. Every experiment utilized this method of deriving a neuronal culture from a pool of spiral ganglia harvested from multiple litter mates. Importantly, while the culture for each experiment was repeated three independent times, the sample size used for statistical analysis for all experiments were the neurons measured in each assessment.

Targeted inhibition of Ca2+ signaling

To selectively modulate Ca2+ signaling, 100 μM ryanodine (Abcam) was used to inhibit RyR signaling and 2 μM xestospongin C (Cayman Chemical) to inhibit IP3 signaling. The drugs and concentrations were chosen based on their prior in studying neurite guidance. 100 μM ryanodine has been shown to trap RyRs in a closed state while not effecting SGN viability [15, 17]. 2 μM xestospongin C has been shown to nearly completely block IP3 transport, while also not effecting SGN viability [17, 36].

Calcium imaging

To study the morphology and behavior of neuron growth cones in response to topographical growth cues, rDRGNs from mice expressing Pirt-GCaMP3, a genetically encoded calcium indicator [22, 37], were cultured on a topographically patterned substrate consisting of repeated rows of ridges and grooves (10 μm periodicity and 3 μm amplitude) and compared against unpatterned substrates. The substrates were made in the same manner as described previously [23].

After overnight incubation, half the media was removed and fresh media containing drug was added. After 1 h incubation with the inhibitor, the sample was placed in an Okolab incubator and imaged with 40x objective using a Lecia DMIRE2 equipped with a FITC/EGFP filter (EX 480nm +/- 20nm, EM 535nm +/- 25nm, Chroma Technology) and a custom filter (EX 405nm +/- 10nm, EM 520nm +/- 20nm, Chroma Technology). Importantly, the Pirt-GCaMP3 enables fluorescent visualization of the entire rDRGN, including the growth cone. In each sample, five growth cones were randomly selected to be imaged. Each growth cone was imaged by three images taken 10 s apart by the two wavelengths.

After images were gathered, relative Ca2+ in the growth cone was determined as follows. First, two signals were averaged from the three images; both from a round region of interest (ROI) which filled the growth cone of interest as much as possible and an ROI from the background adjacent to it. After correcting each wavelength to the background signal, the 535nm (FITC/EGFP) signal was divided by the 520nm signal to find a measure of the relative Ca2+ level. For each experimental replicate, the data was normalized to the level of the untreated neurons cultured on an unpatterned substrate. Since Ca2+ level was compared in response to two potentially interacting variables, substrate and drug treatment, two-way ANOVA was used to assess significance.

Comparing rDRGN growth cone morphology on micropatterned substrate

For the rDRGNs, chicken polyclonal antibody to NF200 (RRID: AB_2313552, Aves) was added (1:800 in blocking buffer) for 1 h at RT. Following this incubation, the culture surface was washed three times with PBS (-/-) and then Goat anti-Chicken Alexa Fluor®488 (RRID: AB_2534096, ThermoFisher) and Alexa Fluor™ 546 Phalloidin (ThermoFisher) (1:200) in blocking buffer (1:1000) was added for 1 h at RT in the dark. Following the secondary antibody incubation, cultures were again washed with PBS (-/-) three times. Lastly, the polymer-coated cover glass was mounted onto a glass slide using Fluoromount-G® (SouthernBiotech) and kept in the dark for 24 h before imaging.

Fixed growth cones were imaged via confocal microscopy (STELLARIS 8, Leica). Images of the growth cones were analyzed by two approaches using Imaris software. First, the shape of the growth cone was computed, in particular, the prolate ellipticity. For this, the software approximated the shape of the growth cone as an ellipsoid and prolate ellipticity was derived as indicated by the equation. Second, the 2D shape of the growth cone was approximated as an ellipse and its major axis was derived. The angle made between this major axis and the neurite shaft was measured to the nearest 5° (Fig 2).

Fig 2. Inhibiting Ca2+ release from internal stores alters growth cone morphology on topographically patterned substrates.

Fig 2

(A-C). Representative images of fixed rDRGN growth cones growing on topographically patterned substrates either untreated (A), treated with 100μM ryanodine (B), or 2μM xestospongin C (C). Growth cone (magenta) was selected and its shape described using Imaris. (D). Growth cone shape was approximated as a spheroid and its prolate ellipticity was calculated. One-way ANOVA with follow-up Dunnett’s multiple comparisons testing shows that untreated growth cones on the patterned substrate had greater prolate ellipticity values. Error bars represent +/-SEM, p < 0.05. E. The major axis of this spheroid was found, and the angle difference between this axis and the neurite shaft was measured to the nearest 5°. Kruskal-Wallis test with follow-up Dunn’s multiple comparisons testing shows that this angle was smaller for the untreated neurons on the patterned substrate. Error bars represent 95% confidence interval. n = 50, 34, 33 growth cones, respectively derived from three independent culture replicates from one neonatal mouse. p < 0.001. Scale bars = 5 μm. † indicates dataset from previously published study.

Immunofluorescent labeling of SGNs

Media was removed and the culture surface was washed three times with phosphate-buffered saline without calcium and magnesium (PBS(-/-)) and 4% paraformaldehyde in PBS(-/-) (Fisher Scientific) was added to fix the cultures. After 20 min at RT, cells were washed with PBS(-/-) three times, and then blocking buffer was added (5% normal goat serum [ThermoFisher], 0.2% Triton™ X-100 [Fisher Scientific], and 1% BSA [Research Products International] in PBS[-/-]). After incubating for 30 min at RT mouse monoclonal anti-NF200 antibody (RRID: AB_260781, Millipore Sigma) was added (1:400 in blocking buffer) for 2 h at 37°C. Following this incubation, the culture surface was washed 3 times with PBS (-/-) and then Goat anti-mouse Alexa Fluor®546 (RRID: AB_2534089, ThermoFisher) in blocking buffer (1:800) was added for 1 h at RT in the dark.

SGNs were grown on these substrates, exposed to the same inhibitors of Ca2+ mentioned above, and their alignment to the stripes was quantified. It is important to note that prior work has shown no effect on viability of neurons grown on these polymer substrates [26]. Neurite alignment to the peptide stripes was quantified by taking the total length of neurite growth and dividing it by the proportion of that length which is in the direction of the pattern [26, 38]. Thus, 1 would indicate perfect alignment while 1.5 would represent a random orientation of growth. This alignment index was also measured for SGNs growing on the EphA4-Fc stripes as well. Kruskal-Wallis was used to compare alignment in both experimental settings.

Quantifying SGN neurite growth in zigzag pattern

Multidirectional topographical substrates were first coated with poly-L-ornithine solution (Sigma-Aldrich) for 1 h at RT. After washing the substrate with H2O, a laminin solution was added (20μg/ml, Sigma-Aldrich) and incubated overnight at 4°C. SGNs grown on these substrates were traced and a variety of measurements were derived. Full neurite tracing was conducted using NeuronJ [39] and data were analyzed via a previously described MATLAB program [25, 28]. First, the neurite tracing is divided into 10 μm length segments and the angle relative to the horizontal direction was calculated, as previously described [27]. Of note, overall, the zigzags run in the horizontal direction and each feature segment is aligned at 45°. Using these angle segments, the number of turns for each neurite is determined. A turn was designated by the MATLAB program if the neurite demonstrated a trajectory difference of at least 10° for three consecutive segments from the previous three consecutive segments [25]. Additionally, the percent of neurite length in the trough of the topographically patterned substrate was determined [25, 28].

Semi-automated measurement of SGN neurite length within microfeature

Another method for assessing neurite pathfinding behavior was studying neurite pathfinding in response to the micropatterned substrate which consisted of six different turn challenges. A first measurement assessed every SGN neurite that encountered a micropatterned, topographical microfeature by measuring the neurite length in the microfeature using NeuronJ [39, 40]. The neurite length in microfeatures was measured from where the neurite entered the microfeature to where it either exited the microfeature or the endpoint of the neurite. These length data were then grouped both by turn angle and drug treatment. For this approach, the unpatterned control condition was generated by overlaying the shape of the 60° microfeature over a flat portion of the substrate, and length data was measured in the same manner as neurites encountered this pseudo-pattern. Two-way ANOVA was used to statistically assess these data since SGN neurite behavior was compared in response to two potentially interacting variables, turn angle and drug treatment.

Manual assessment of SGN neurite pathfinding

Another method for assessing neurite pathfinding behavior was qualitatively scoring every neurite encounter with one of the five angled microfeature turn challenges on the micropatterned substrate [40]. Neurites were scored as either turning or not turning. In particular, two conditions in which neurites were scored as not turning included: 1. not following the microfeature; neurite growth not orienting in the direction of the pattern and the neurite crossing the microfeature in the direction approximately perpendicular to the microfeature direction, and 2. neurite following the straight portion of the microfeature but failing to complete the turn challenge and crossing the microfeature. Additionally, two categories of neurites were deemed to successfully turn in response to the microfeatures, as previously described [40], including: 1. neurite following microfeature and navigating one turn; the neurite entering the microfeature more than 30 μm before the turning challenge and remaining positioned in the microfeature 30 μm past the vertex of the turning challenge, as well as 2. neurite navigating multiple turns and/or the shaft reorienting where it is aligned across multiple of the zigzagging microfeatures.

Assessing SGN ability to remain in the microfeature around a turn

Since the neurons encountered turn challenges of various microfeature amplitudes, the tendency of these neurons to keep their shaft in the microfeature around a turn was assessed, as previously described [40]. For this, the SGNs which successfully turned in response to the topographical microfeature in the analysis above (Manual assessment of SGN neurite pathfinding) were further studied. The proportion of neurites that remained in the microfeature around the turn was determined and, subsequently, the proportions were statistically compared with chi-squared testing.

Live DRGN imaging

Neurons growing in response to micropatterned surfaces were imaged live. To do this, rDRGNs were cultured from mice expressing Pirt-GCaMP3, a genetically encoded calcium indicator. These neurons were cultured on multiangled substrates with 4 μm microfeatures for 18 h after replating. At that timepoint, neurites that were currently growing in a microfeature, actively engaging with the ridge of the feature, and were facing a turn challenge were selected randomly and imaged at a frequency of 15 s for 1.5 h to capture the growth dynamics. These videos were assessed by tracking the growth cones for the duration of the recording and then scored as either turn, exit, or stall based on how they grew for the 1.5 h.

Results

Basal Ca2+ level in growth cones increases on patterned substrate via IP3 and RyR signaling

Neurons were grown on a topographically patterned substrate consisting of alternating gradually sloped ridges and troughs with an amplitude of 3μm and periodicity of 10μm, as previously described [23, 32, 40]. This system was utilized since it is assumed that the growth cone is always in contact with the ridges of the microfeature. Thus, whatever signaling is utilized by the neuron to sense and grow in response to the topographical features ought to be constitutively active. Replated DRGNs were harvested from Pirt-GCaMP3 transgenic mice and plated on these substrates, as well as on unpatterned substrates as a control, and imaged live to assess the Ca2+ level in their growth cones (Fig 1A–1C). In the untreated conditions, the mean normalized Ca2+ level is elevated by approximately 10% in the growth cone as the neurites are navigating the narrow topographical microfeatures (Fig 1D). However, if RyR signaling (with 100μM ryanodine) or IP3 signaling (2μM xestospongin C) is inhibited, the Ca2+ level in the growth cones of the rDRGNs growing on the substrate does not increase in the neurons growing on the patterned substrate (Fig 1D). This finding implies that topographical patterns increase Ca2+ levels by inducing Ca2+ release from internal stores via RyR and IP3 signaling.

Fig 1. Basal Ca2+ level in growth cones increases on patterned substrate via IP3 and RyR signaling.

Fig 1

(A-C) Representative images of rDRGN growth cones expressing Pirt-GcaMP3 growing on topographically patterned substrates either untreated (A), treated with 100μM ryanodine (B), or 2μM xestospongin C (C). (D) Ca2+ signal in the growth cones which is background corrected and normalized to the unpatterned untreated condition. Two-way ANOVA with follow-up Dunnett’s multiple comparison testing suggests that the patterned untreated condition is the only significantly different condition (p < 0.01). n = 26–35 growth cones per condition from three independent culture replicates from one neonatal mouse. Error bars represent +/-SEM. Scale bar = 5μm.

Growth cone morphology on topographically patterned substrates is altered when inhibiting Ca2+ release from internal stores

Next, the shape of the growth cone as it navigates these features was studied in order to better understand how a rDRGN growth cone alters its morphology in response to topographical growth cues. In untreated growth cones on these patterned substrates (Fig 2A), the shape of a growth cone is more elongated and prolate relative to growth cones on unpatterned surfaces(Fig 2D) [40]. Additionally, the angle between the major axis of the growth cone and the neurite shaft is aligned (Fig 2E). However, when RyR signaling (Fig 2B) or IP3 signaling (Fig 2C) is inhibited in neurons growing on the patterned substrates, the treated growth cones become less prolate in shape (Fig 2D). Furthermore, the treated neurons display a near random orientation of their growth cones relative to their neurite shafts (closer to 45°) (Fig 2E). This observation, when combined with the observations in Fig 1, implies that these two mechanisms of Ca2+ release are necessary for growth cones to change their morphology and growth trajectory as the growth cones navigate in response to topographical cues.

SGNs guidance to chemo-permissive laminin stripes depends on RyR and IP3 signaling

Given that IP3 and RyR signaling enable alignment to biophysical cues [17], next we assessed if these signaling pathways are also required for SGNs to align to biochemical cues. To do this, SGNs were cultured on a substrate consisting of laminin stripes 25μm alternating with 25μm of photo-deactivated laminin, thus creating a chemo-permissive growth cue. In this experimental system, SGN neurites strongly align to the laminin stripes with a median Alignment Index of 1.15 (Fig 3A). Inhibition of RyR (Fig 3B) or IP3 signaling (Fig 3C) significantly disrupts SGN neurite alignment to the laminin stripes by significantly increasing the median Alignment Index to 1.28 and 1.30, respectively (Fig 3D). Notably, no difference in total neurite length was measured, thus the alignment differences cannot be explained by growth differences (S2 Fig).

Fig 3. Inhibiting Ca2+ release from internal stores impairs the ability SGNs to follow chemo-permissive laminin stripes.

Fig 3

(A-C). Representative images of fixed SGNs growing in laminin stripe patterned substrates either untreated (A), treated with 100μM ryanodine (B), or 2μM xestospongin C (C) NF200 is labeled green and laminin red. (D) Alignment Index (Total neurite length divided by length in horizontal direction) of SGNs to the micropatterned laminin substrates. Kruskal-Wallis with follow-up Dunn’s multiple comparisons testing shows that both treatments impair the ability of SGNs to align to the laminin stripes. Graph shows median Alignment Index +/- 95% CI, p < 0.05. n = 38, 59, 52, 36 neurons derived from three independent culture replicates of a pool of spiral ganglia harvested from multiple litter mates. Scale bar = 50 μm.

SGNs guidance to chemo-repulsive EphA4-Fc stripes depends on RyR and IP3 signaling

EphA4-Fc serves as a chemo-repulsive cue to SGN neurite growth in vivo and in vitro [29, 30, 32]. To explore the role of internal Ca2+ release to chemo-repulsive SGN neurite guidance, SGNs were cultured on a substrate consisting of EphA4-Fc stripes, repeating every 25μm, adsorbed on a uniform laminin coating [28]. In this experimental system, SGN neurites moderately align to the EphA4-Fc stripes with a median Alignment Index of 1.21 (Fig 4A). Similar to with the laminin stripes (Fig 3), inhibition of RyR (Fig 4B) or IP3 signaling (Fig 4C) significantly disrupts SGN neurite alignment to EphA4-Fc stripes to a median Alignment Index of 1.37 and 1.33, respectively (Fig 4D). Importantly, while there were observed differences in neurite alignment, no difference in total neurite length was measured (S3 Fig).

Fig 4. Inhibiting Ca2+ release from internal stores impairs the ability SGNs to follow chemo-repulsive EphA4 stripes.

Fig 4

(A-C). Representative images of fixed SGNs growing in on EphA4-Fc stripe patterned substrates either untreated (A), treated with 100μM ryanodine (B), or 2μM xestospongin C (C). NF200 is labeled aqua, laminin labeled pink, and EphA4-Fc blue. (D) Alignment Index (Total neurite length divided by length in horizontal direction) of SGNs to the micropatterned EphA4-Fc substrates. Kruskal-Wallis with follow-up Dunn’s multiple comparisons testing shows that both treatments impair the ability of SGNs to align to the EphA4-Fc stripes. Graph shows median Alignment Index +/- 95% CI, p < 0.05. n = 38, 33, 33, 39 neurons derived from three independent culture replicates of a pool of spiral ganglia harvested from multiple litter mates. Scale bar = 50 μm.

Inhibiting RyR or IP3 signaling causes two different impaired guidance phenotypes in SGNs growing on to zigzag biophysical micropattern

Given that inhibition of RyR or IP3 signaling impairs SGN alignment to unidirectional topographically and biochemically patterned substrates, next guidance in response to multidirectional cues was assessed. To accomplish this, a topographically patterned substrate consisting of alternating gradually sloped ridges and troughs was engineered using a photomask with zigzagged bands of shaded and unshaded regions [25]. The geometry of the substrate is as follows: amplitude of 4μm, periodicity of 50μm, angle of zigzag is 90°, straight segment of zigzag is 75μm. As this patterned substrate presents a more complex geometry, different and more relevant metrics are needed to analyze SGN growth behavior. A first approach is to trace the neurites, divide the data into 10μm length segments, and then calculate and bin the angle relative to the horizontal direction for each segment. In this, untreated SGNs (Fig 5C) grown on the zigzag pattern tended to have segments aligned to the horizontal and then a gradual decay of proportion as the angle relative to the horizontal is increased (Fig 5F). When treated with either ryanodine (Fig 5D) or xestospongin C (Fig 5E), this distribution becomes less pronounced and more random. However, a more detailed assessment of the treatment groups reveals some nuanced differences. Looking at the xestospongin C treated SGN segment angle data, a minor, but notable, increase is present in the intermediate angles. This is represented by neurites in xestospongin C treated cultures having an increased frequency of segments near 45°, the angle of each segment of the zigzag pattern (Fig 5G). An additional method is to determine the proportion of neurite length that is within the trough of the microfeature. For this measurement, even though the xestospongin C treated SGNs have an altered distribution of angle segments, the same proportion of the total neurite shaft length is present in the trough of the zigzag microfeature (Fig 5H). This observation contrasts with the neurite growth behavior in the ryanodine treated SGNs which appears to approximate SGNs on unpatterned substrates, suggesting a more general impaired alignment to these multidirectional cues. First, the ryanodine treated neurons exhibit a significantly smaller proportion of their total length in the microfeature trough (Fig 5H) compared to untreated neurons on these patterned surfaces. Additionally, the number of turns a neurite makes can be calculated and, similar to neurons grown on unpatterned substrates, the ryanodine treated neurons display a greater number of turns per unit length than untreated neurons on the zigzag pattern (Fig 5I). Lastly, no difference in total neurite length was observed between the treatment groups (S4 Fig).

Fig 5. Inhibiting RyR or IP3 signaling causes different impairment of neurite guidance on a zigzag micropattern.

Fig 5

(A) SEM image of the topographically micropatterned zigzag substrate. (B) Representative image of fixed SGNs growing on unpatterned substrate.(C-E). Representative images of fixed SGNs growing on topographically micropatterned zigzag substrate either untreated (C), treated with 100μM ryanodine (D), or 2μM xestospongin C (E). (F) Distribution of SGN neurite segment angles relative to the horizontal axis. (G) Proportion of neurite segments which are oriented between 40° and 50° relative to the horizontal, i.e., the angle of each segment of the zigzag micropattern. Error bars are +/- standard error of proportion. Significance indicated for chi-square test with follow-up z-testing. p < 0.01. (H) Average percent of length for each neuron that is in the micropatterned feature. 50% would represent a random tendency for the neuron. (I) Average number of turns measured per neuron normalized by 100 μm of length. For H & I, one-way ANOVA with follow-up Dunnett’s multiple comparisons testing was done to compare groups. Error bars are +/- SEM, p < 0.05. n = 53, 100, 109, 89 neurons derived from three independent culture replicates of a pool of spiral ganglia harvested from multiple litter mates. Scale bar = 50 μm.

Ryanodine treatment inhibits the ability of SGN neurites to navigate complex biophysical turn challenges, while xestospongin C treatment promotes aligning across the angled feature

These observations imply distinct roles of these two signaling pathways in neurite guidance and prompted further research into how RyR and IP3 signaling impact SGN neurite guidance to more complex geometry topographical cues. Thus, a biophysical substrate was engineered consisting of six different angled microfeature turn challenges, ranging from 30–180 (straight) degrees [40], where the angled channels are not overlapping with each other as occurs with the zigzag system pattern (Fig 5A). Neurite pathfinding in response to this system is complex and the effect size is small, due in part to the fact that the pattern only occupies a small percentage of the overall surface area of the substrate. These limitations are offset by the substrate facilitating analyses of growth cone and neurite behavior at specific topographical microfeatures. A first method to quantify the SGN behavior in response to these angled turns is to measure the length each neurite navigates in the microfeatures. This was done by tracing the length from the point where the neurite entered the microfeature to where it either exited the microfeature or the endpoint of the neurite was reached. In this metric, untreated SGN neurites (S5A Fig) track inside the microfeatures significantly longer than both the ryanodine (S5B Fig) and xestospongin C (S5C Fig) treated groups. In particular, there was approximately a 20% reduction in median tracking in both treatment groups (S5D Fig).

Additionally, this same experimental system was used to more thoroughly assess neurite behavior by employing another method to quantitatively score each neurite encounter with an angled microfeature. In this other analysis, neurites were classified as (1) does not follow (Fig 6A), (2) makes a turn (Fig 6B), or (3) aligns across the zigzag (Fig 6C). Notably, classifications (2) and (3) were both deemed to be behaviors of neurites following an angled guidance cue. The proportions were plotted as a stacked bar graph for each angle turn and treatment group (Fig 6D). Interestingly in this assessment, xestospongin C treated SGNs follow the microfeature turns to the same extent as untreated SGNs. In particular, xestospongin C treated SGNs are observed frequently aligning across the zigzag in the sharp angle turn conditions (Fig 6C and S5C Fig). Significantly, the proportion of neurites that remain in the channel around the turn are reduced in the xestospongin C treated group (Fig 6E).

Fig 6. Xestospongin C treated SGNs follow the turn challenges, but do not remain in the microfeature.

Fig 6

(A-C). Representative images of fixed SGNs growing in response to topographical microfeature turn challenges. (A) SGN not following the microfeatures (B) SGN making a turn and holding its position in a 90° feature turn, (C) SGN aligning across the 45° turn microfeature. (D) Proportion of neurites which were observed to follow microfeature turns by angle and drug treatment. Patterned segment of a bar is the proportion which made one turn, while solid demonstrated alignment across multiple turns. Multinomial logistic regression shows effect of Ryanodine treatment and microfeature angle on guidance. Measurements in each treatment were compiled and results from Chi-square test with follow up z-tests shown for overall data. Error bars represent +/- standard error for a proportion. n = 103, 155, 155. (E) Proportion of the neurites that made a turn and held its position in the microfeature. Chi-squared test with follow up z-tests indicate a lower proportion of xestospongin C treated remain in the channel during a turn. Error bars +/- SEM, p < 0.05. n = 22, 17, 36 neurite shafts from three independent culture replicates of a pool of spiral ganglia harvested from multiple litter mates. Scale bar = 50 μm.

Real time analysis of growth cone behavior suggest role of RyR signaling in growth cone repulsion and IP3 signaling in turning

Given the challenges and limitations in analyzing neurite guidance using fixed cultures in complex topographically patterned systems, next rDRGNs from Pirt-GCaMP3 transgenic mice were cultured and imaged in real time for 1.5h as they grew on micropatterned substrate. The features in these micropatterns were engineered with moderate amplitudes (4 μm), so that neurites would be responsive but not constrained by the microstructure. In the videos, the untreated growth cones were highly dynamic and reacted to the microfeature ridges in the 4μm amplitude condition (Fig 7A and 7B). In this dynamic system, growth cones were imaged as they encountered a micropattern feature and their behavior scored as turn, stall, or exit. In untreated growth cones(Fig 7A and 7B), there is roughly an even distribution of behavior by turning, stalling, or exiting, 27%, 40%, and 33% respectively. Ryanodine treatment led to a strong decrease in the stalling behavior (0%) with an increase in exiting (80%) behavior (Fig 7C and 7D). Conversely in the xestospongin C treated cultures (Fig 7E and 7F), there is a modest decrease in the proportion turning (12.5%) and an increase in the proportion stalling (50%) (Fig 7G).

Fig 7. Ryanodine treated growth cones do not respond to the biophysical microfeatures while xestospongin C treated turn at a decreased frequency.

Fig 7

(A, B) Before and after images of an untreated growth cone navigating a turn. Black circle shows same ROI in each and new growth is marked by green asterisk in B. (C, D) Before and after images of an 100μM ryanodine treated growth cone that exited the microfeatures after encountering a turn. Blue circle shows same ROI in each and new growth is marked by green asterisk in D. (E, F). Before and after images of an 2μM xestospongin C treated growth cone that stalled after encountering a turn. Red circle shows same ROI in each. G. Frequency comparison of turning behaviors of rDRGN growth cones while navigating 4μm amplitude. Chi-squared test with follow up z-tests indicate a lower proportion of ryanodine treated neurite display stalling and xestospongin C treated turn. n = 22, 22, 23 growth cones derived from six independent culture replicates from one neonatal mouse. Scale bar = 10 μm.

Discussion

Medical device and bioengineers aspire to improve the interface between neural prosthetic electrodes and their target neurons. In this pursuit, they seek to engineer biomaterial surfaces or coatings of the electrode to guide neurite outgrowth into close proximity to or contact with the electrode array [5, 4143]. In regard to CIs, neurotrophic molecule gradients, patterned biochemical cues, and topographical surface features have been explored as methods to steer SGN neurite outgrowth towards CI electrodes [4447]. Based on prior work showing its key role in neurite pathfinding, understanding the role of Ca2+ signaling in facilitating neurite guidance in response to varied growth cues helps in efforts to accurately orchestrate this process. Thus, in this study we provide compelling evidence on the role of two sources of Ca2+ release from internal stores, IP3 and RyR, and their respective roles in how growth cones of sensory neurons navigate in response to biochemical and biophysical cues.

IP3 and RyR act in the growth cone when neurites are navigating biophysical cues

As prior work has demonstrated, these signaling pathways are required for neurites to align their growth in response to topographical microfeatures [17], and IP3 signaling occurs in the growth cone during pathfinding to chemo-attractive cues [15, 16]. Thus, we first assessed the role of RyR and IP3 signaling in the growth cone during pathfinding in response to topographical guidance cues. First, there is typically an increase in growth cone Ca2+ as neurites sense and pathfind in response to these biophysical cues. However, if either IP3 or RyR signaling is inhibited, this increase in growth cone Ca2+ is blunted (Fig 1).

These findings suggest the presence of RyR and IP3 signaling pathways in the growth cone during neurite pathfinding in response to biophysical cues. To further explore their contribution to SGN neurite pathfinding we assessed growth cone morphology on the micropatterned substrates in the absence or presence of inhibitors. Typically, when grown on parallel rows of repeating microfeatures of ridges and troughs, the growth cone becomes prolate in shape and its long axis is aligned with the neurite shaft [40]. However, if IP3 or RyR signaling is inhibited, the growth cone become less prolate in shape (Fig 2D) and the growth cone and neurite shaft become less aligned in their orientation (Fig 2E). Combining these observations, it appears that growth cones engage both RyR and IP3 signaling pathways as they sense and grow in response to biophysical guidance cues.

IP3 and RyR signaling are also integral to SGN pathfinding in response to biochemical cues

Next, we assessed the role of these signaling pathways in SGN pathfinding in response to micropatterned biochemical substrates. Prior work has shown that growth cones recruit similar signaling mechanisms in response to these biophysical cues as chemo-repulsive cues. For example, biophysical and chemo-repulsive cues activate RhoA and Rho associated kinase to mediate growth cone guidance [11, 48]. Likewise, elevation of cyclic adenosine monophosphate enables SGN growth cones to grow beyond biophysical and chemo-repulsive borders [17, 49]. Additionally, others have shown differential roles of IP3 and RyR signaling in turning in response to chemo-attractive cues [15]. Thus, we engineered two different biochemically micropatterned substrates: chemo-permissive laminin stripes [27] and chemo-repulsive EphA4-Fc stripes [28, 32]. First in the chemo-permissive system SGN neurites strongly track the laminin stripe, however, when IP3 or RyR signaling was inhibited the neurites tended to wander and not be aligned as strongly in the direction of the stripes (Fig 3).

In the second system, SGN neurites avoid the EphA4-Fc stripes. Similar to the chemo-permissive system, treatment with ryanodine or xestospongin C impaired neurite guidance in response to these chemo-repulsive stripes (Fig 4). Together the data suggest that the function of these two signaling pathways extend beyond being secondary messengers for mechanosensitive channels in responding to biophysical cues. Ca2+ release from internal stores appears to contribute to growth cones ability to sense and pathfind in response to biochemical cues as well.

Neurite pathfinding to multi-directional micropatterns and turn challenges cues reveals differential roles of IP3 and RyR signaling

While the data here suggest that IP3 and RyR signaling both contribute to growth cone pathfinding, work by others has identified situations where they function differently in neurite guidance [14, 15]. Therefore, we sought to study the role of these signaling in pathfinding to more complex multidirectional microfeatures to ascertain if they have distinct roles in the orchestrated process of a growth cone sensing a repulsive cue, halting growth, coordinating a turn, and growing in a new direction.

A first system to test this is culturing SGNs on repeating zigzagging microfeatures with 90° turns [25]. Normally on this substrate, the neurites align in the horizontal direction of the zigzags and tend to somewhat track the microfeatures (~2/3 of neurite length remains in the features). We see that SGN neurites treated with either ryanodine or xestospongin C display impaired guidance to these zigzags micropatterns (Fig 5C–5F). Further assessment of the behavior of the neurites on this system suggests differential behavior of the treatment groups. First, when inhibiting RyR signaling, the neurites display a generalized shift in behavior towards that expected with neurons growing on an unpatterned substrate: modest shift in segment orientation towards randomness (Fig 5F), neurites spend less time in the microfeature trough (Fig 5H), and the neurites tend to turn or wander more frequently (Fig 5I). Overall, this difference implies a general inhibition of the ability of the growth to pathfind in response to the multidirectional biophysical cues with RyR inhibition. However, IP3 signaling inhibition results in a different pathfinding behavior, as the neurites follow the zigzags in a more subtle way. Neurites treated with xestospongin C still respond to the multidirectional microfeatures as they have the same proportion of their length in the trough as the untreated condition (Fig 5H). However, neurites in cultures treated with Xestospongin C demonstrate a higher proportion of their length aligned in the diagonal direction of zigzag (Fig 5G). It is challenging to determine the specific effect that IP3 signaling plays in neurite pathfinding using these data alone, prompting the need for further study of growth cones sensing and turning in response to other cues of complex geometries.

Thus, in the next system we assessed the neurite’s ability to track and turn in response to various microfeature turn challenges [40]. In the system engineered herein, the micropatterned features present angles ranging from 30–180 degrees and comprise only a small percentage of the overall surface area. In 4 μm amplitude microfeatures, untreated neurites do not follow this system very strongly due to the random nature in which the neurites encounter the turn challenges. However, similar to the multidirectional micropatterned system above, the contribution of RyR and IP3 signaling becomes clearer with further assessment of neurite behavior. A first measurement of how well a neurite follows these turns is to measure how long the neurite remains in the microfeatures. In this, we see a significant reduction in length followed in both the ryanodine and xestospongin C treatment groups (S5 Fig). Next, we categorically assessed how well the neurites turned in response to the microfeatures using both fixed (Fig 6) and real time systems (Fig 7). RyR inhibition blunted the ability of neurites to navigate these biophysical cues manifesting as a reduction in the ability of the neurites to turn and follow the cues in the fixed system (Fig 6) as well as a reduction in engagement with the microfeature ridge during live imaging (Fig 7). Together these findings suggest an overall impairment in sensing and responding to the biophysical features when RyR is inhibited.

In assessing the ability of the xestospongin C treated neurites to turn in response to the micropatterns, an interesting trend emerges. First in the fixed system, xestospongin C treated SGNs follow the microfeature turns as well as the untreated SGNs. In particular, an increased proportion of the neurites align across the zigzag (Fig 6C and 6D) in the sharp angle turn challenges (30° and 45°). These neurites remain in the microfeature trough at much reduced rate compared to untreated cultures (Fig 6E). This behavior implies that inhibition of IP3 signaling results in a greater number of neurites that grow straight across the angled features. This observation is consistent with what is seen with these same neurites in live imaging. First, IP3 inhibition reduces neurites turning in response to the features and importantly, also increases the proportion of neurites that stall at the feature edge (Fig 7). The predisposition of neurites treated with Xestospongin C to cut across the zigzagging turning features coupled with their stalling at feature edges suggests that IP3 signaling enables growth cones to coordinate turning behavior in response to microtopographical features, i.e. when IP3 signaling is inhibited growth cones appear to sense the ridge, stall, fail to coordinate a turn, and then grow straight across the microfeature.

Integrating into a model of neurite guidance to repulsive substrate cues

A significant body of work has revealed the role of Ca2+ and IP3 signals in integrating growth cone responses to guidance cues. Prior to integrating a model of growth cone guidance to the patterned substrates used here, it is important to understand the characteristics of the diverse cues used in the various experimental systems in previous studies and the Ca2+ signals they induce. Importantly, the guidance cues engineered here differ from instantaneous chemical gradient perfusion or microinjections into the cytoplasm. These patterned substrates are designed such that the growth cones encounter robust and consistent growth cues. Extra- or intracellular injections result in transient changes to Ca2+ signaling [15, 18, 50, 51], while in the topographically patterned substrates the growth cones interact with a consistent cue through time and space. This is important since neurite guidance is governed by both the temporal and spatial aspects of Ca2+ signaling [13, 14, 52]. Further, various attractive cues induce different signaling pathways in the growth cone [15, 51]. These nuanced differences in methodologies combined with the intricacies of the tightly choreographed role of Ca2+ level in growth cone pathfinding should be appreciated to help integrate these data here with other presented in the field.

Research into the role of RyR signaling, Ca2+ induced Ca2+ release (CICR), and Ca2+ elevation in neurite guidance likewise presents a complex picture. For example, the findings range from RyR being involved in sensing repulsive cues [17], to CICR via RyR acting as a crucial mediator for attractive turning [18, 51]. Furthermore, asymmetrical increases in Ca2+ in the growth cone arising from guidance cues present additional nuance; small elevations in Ca2+ via extracellular sources as well as large or global increases in Ca2+ both lead to repulsion, whereas moderate, asymmetrical elevations in Ca2+ levels induce attraction [13, 52].

With these nuances in mind, we can integrate the data presented here into a model of the role of Ca2+ and IP3 signaling in the growth cone as neurites navigate biophysical or biochemical micropatterned features. Prior work suggests that topographical microfeatures function as a repulsive cue and recruit similar downstream signaling as chemo-repulsive molecules including RhoA and Rho associated kinase [11]. In the model presented here, the growth cone initially senses the repulsive cue and initiates a local increase in Ca2+ (repulsive signal) though plasma membrane sensors and channels [11, 32, 5356]. This localized Ca2+ elevation results in CICR via RyRs (Fig 8A). Importantly, this CICR is expected to be sufficiently robust in magnitude, spatially and temporally, to stall growth extension localized to region of the growth cone interacting with the microfeature (e.g., ridge or chemo-repulsive border) [9, 57].

Fig 8. Model of RyR and IP3 signaling in neurite guidance to patterned substrate cues.

Fig 8

A. A stalled neurite whereby a repulsive cue initiates Ca2+ influx via yet to be identified plasma membrane sensors and channels, which may vary for each type of repulsive cue. This local increase in Ca2+ leads to RyR mediated CICR and repulsion. B. A turning neurite whereby the phenomenon in Fig 8A is occurring in the region being turning away from. While in the region being turned toward, the growth cone is sensing attractive cues on the permissive substrate, which triggers IP3 signaling and attractive growth.

For neurite turning to a repulsive cue, if the growth cone encounters the repulsive cue at an angle, it is suspected that RyR-mediated CICR is localized to the region of growth cone interacting with the feature. The other side of the growth cone, engaging a permissive substrate (e.g., biophysical groove or laminin coating), would extend via IP3 signaling induced attraction [15, 5861] (Fig 8B). IP3 signaling has been shown to harmonize turning in response to chemo-attractive cues, such as a gradient of diffusible attractive cues (e.g., neurotrophins) [15, 17] whereby IP3 signaling coordinates asymmetrical Ca2+ signaling in the growth cone [16]. This spatial asymmetry in RyR-mediated CICR and IP3 signaling would lead to the coordinated turning observed. In combination, the findings suggest that RyR-mediated CICR and IP3 signaling play distinct roles in coordinating neurite pathfinding. Their roles combine to orchestrate growth cone guidance in response to the cues studied here.

Conclusions

Here we use a variety of engineered micropatterned substrates to probe the role of IP3 and RyR signaling for sensory neuron neurite pathfinding. Our data suggest that these mechanisms for Ca2+ release from internal stores play essential and distinct roles in the process. First, RyR signaling appears critical for growth cones to halt growth upon encountering patterned, repulsive substrate cues. Meanwhile, IP3 signaling appears necessary for coordinated growth cone turning. Taken together, these data highlight the overlap in the intracellular signaling processes governing neurite guidance in response to a diversity of cues and motivates further work on the role of these pathways in regenerative pathfinding using in vivo models.

Supporting information

S1 Fig. Methods to measure neurite behavior in response to angled topographical microfeature.

(A) Schematic demonstrating the derivation of percent of neurite length in topographical microfeature. (B) Schematic demonstrating calculation of turns. Neurite is segmented in to 10 μm segments and the angle relative to the horizontal calculated for each segment. The MATLAB program counts a turn when 3 consecutive segments vary by >10°. (C) Schematic demonstrating the measurement of the length a neurite remains in topographical microfeature. Scale bars = 50 μm.

(TIF)

pone.0308389.s001.tif (835KB, tif)
S2 Fig. Inhibiting Ca2+ release from internal has no effect on SGN neurite length on chemo-permissive laminin stripes.

Total neurite length of SGNs cultured in the respective conditions. Kruskal-Wallis testing shows no effect of treatment on SGN neurite growth. Graph shows median Alignment Index +/- 95% CI. n = 38, 59, 52, 36 neurons.

(TIF)

pone.0308389.s002.tif (95.8KB, tif)
S3 Fig. Inhibiting Ca2+ release from internal has no effect on SGN neurite length on chemo-repulsive EphA4 stripes.

Total neurite length of SGNs cultured in the respective conditions. Kruskal-Wallis testing shows no effect of treatment on SGN neurite growth. Graph shows median Alignment Index +/- 95% CI. n = 38, 33, 33, 39 neurons.

(TIF)

pone.0308389.s003.tif (96.1KB, tif)
S4 Fig. Inhibiting RyR or IP3 signaling has no effect on neurite length on a zig zag Micropatterned Substrate.

Total neurite length of SGNs cultured in the respective conditions. Kruskal-Wallis testing shows no effect of treatment on SGN neurite growth. Graph shows median Alignment Index +/- 95% CI. n = 53, 100, 109, 89 neurons.

(TIF)

pone.0308389.s004.tif (126.4KB, tif)
S5 Fig. Inhibiting Ca2+ release from internal stores impairs guidance to angled biophysical microfeatures.

(A-C). Representative images of fixed SGNs growing in response to topographical microfeature turn challenges either untreated (A), treated with 100μM ryanodine (B), or 2μM xestospongin C (C). (D) Length neurite remains in topographical microfeature once encountering it. Two-way ANOVA on ranks suggests that both treatments impair the ability of SGNs to follow the topographical microfeature turn challenges and length followed increases with more gradual turns. Data are 95% confidence interval box and whisker. n = 29, 645, 355, 348 neurite encounters. Scale bar = 100 μm.

(TIF)

pone.0308389.s005.tif (222.2KB, tif)
S1 Data. Raw data corresponding to Figs 5, 6D and S4.

(XLSX)

pone.0308389.s006.xlsx (33.8KB, xlsx)
S1 File. Additional description of statistics and data visualization.

(PDF)

pone.0308389.s007.pdf (122.2KB, pdf)

Acknowledgments

The Pirt-GCaMP3 transgenic mice were gifted from Dr. Xinzhong Dong of John Hopkins University.

Abbreviations

BDNF

Brain-derived neurotrophic factor

CI

Cochlear implant

DRGN

Dorsal root ganglion neuron

FBS

Fetal bovine serum

HBSS

Hanks’ balanced salt solution

HDDMA

1,6-hexanediol dimethacrylate

HMA

hexyl methacrylate

IP3

inositol tripohosphate

NF200

High molecular weight neurofilament protein

NT-3

Neurotrophin-3

PBS

Phosphate buffered saline

RyR

Ryanodine receptor

SGN

spiral ganglion neuron.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

MH and AG: NIH-NIDCD R01-DC012578 JV: NIH-NIDCD F31-DC020371, and University of Iowa: NIGMS T32-GM007337.

References

  • 1.McCormick LE, Gupton SL. Mechanistic advances in axon pathfinding. Current Opinion in Cell Biology. 2020;63:11–9. doi: 10.1016/j.ceb.2019.12.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Domínguez-Romero ME, Slater PG. Unraveling Axon Guidance during Axotomy and Regeneration. International Journal of Molecular Sciences. 2021;22(15):8344. doi: 10.3390/ijms22158344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schmidbauer D, Fink S, Rousset F, Löwenheim H, Senn P, Glueckert R. Closing the Gap between the Auditory Nerve and Cochlear Implant Electrodes: Which Neurotrophin Cocktail Performs Best for Axonal Outgrowth and Is Electrical Stimulation Beneficial? International Journal of Molecular Sciences. 2023;24(3):2013. doi: 10.3390/ijms24032013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Aregueta-Robles UA, Woolley AJ, Poole-Warren LA, Lovell NH, Green RA. Organic electrode coatings for next-generation neural interfaces. Frontiers in Neuroengineering. 2014;7. doi: 10.3389/fneng.2014.00015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Thompson CH, Zoratti MJ, Langhals NB, Purcell EK. Regenerative Electrode Interfaces for Neural Prostheses. Tissue Eng Part B Rev. 2016;22(2):125–35. doi: 10.1089/ten.TEB.2015.0279 [DOI] [PubMed] [Google Scholar]
  • 6.Reich U, Fadeeva E, Warnecke A, Paasche G, Müller P, Chichkov B, et al. Directing neuronal cell growth on implant material surfaces by microstructuring. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2012;100B(4):940–7. doi: 10.1002/jbm.b.32656 [DOI] [PubMed] [Google Scholar]
  • 7.Aurand ER, Usmani S, Medelin M, Scaini D, Bosi S, Rosselli FB, et al. Nanostructures to Engineer 3D Neural-Interfaces: Directing Axonal Navigation toward Successful Bridging of Spinal Segments. Advanced Functional Materials. 2018;28(12):1700550. [Google Scholar]
  • 8.Blasiak A, Ng KA, Wong MDS, Tsai CW, Rusly A, Gammad GGL, et al. STEER: 3D Printed Guide for Nerve Regrowth Control and Neural Interface in Non-Human Primate Model. IEEE Transactions on Biomedical Engineering. 2022;69(3):1085–92. doi: 10.1109/TBME.2021.3113653 [DOI] [PubMed] [Google Scholar]
  • 9.Henley J, Poo MM. Guiding neuronal growth cones using Ca2+ signals. Trends Cell Biol. 2004;14(6):320–30. doi: 10.1016/j.tcb.2004.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wen Z, Guirland C, Ming G-l, Zheng JQ. A CaMKII/calcineurin switch controls the direction of Ca2+-dependent growth cone guidance. Neuron. 2004;43(6):835–46. [DOI] [PubMed] [Google Scholar]
  • 11.Li S, Tuft BW, Xu L, Polacco MA, Clarke JC, Guymon CA, et al. Microtopographical features generated by photopolymerization recruit RhoA/ROCK through TRPV1 to direct cell and neurite growth. Biomaterials. 2015;53:95–106. doi: 10.1016/j.biomaterials.2015.02.057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kerstein PC, Nichol RH, Gomez TM. Mechanochemical regulation of growth cone motility. Frontiers in Cellular Neuroscience. 2015;9. doi: 10.3389/fncel.2015.00244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gasperini RJ, Pavez M, Thompson AC, Mitchell CB, Hardy H, Young KM, et al. How does calcium interact with the cytoskeleton to regulate growth cone motility during axon pathfinding? Molecular and Cellular Neuroscience. 2017;84:29–35. doi: 10.1016/j.mcn.2017.07.006 [DOI] [PubMed] [Google Scholar]
  • 14.Akiyama H, Kamiguchi H. Second messenger networks for accurate growth cone guidance. Developmental Neurobiology. 2015;75(4):411–22. doi: 10.1002/dneu.22157 [DOI] [PubMed] [Google Scholar]
  • 15.Akiyama H, Matsu-ura T, Mikoshiba K, Kamiguchi H. Control of neuronal growth cone navigation by asymmetric inositol 1,4,5-trisphosphate signals. Sci Signal. 2009;2(79):ra34. doi: 10.1126/scisignal.2000196 [DOI] [PubMed] [Google Scholar]
  • 16.Chan C, Ooashi N, Akiyama H, Fukuda T, Inoue M, Matsu-Ura T, et al. Inositol 1,4,5-Trisphosphate Receptor Type 3 Regulates Neuronal Growth Cone Sensitivity to Guidance Signals. iScience. 2020;23(3):100963. doi: 10.1016/j.isci.2020.100963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Li S, Tuft B, Xu L, Polacco M, Clarke JC, Guymon CA, et al. Intracellular calcium and cyclic nucleotide levels modulate neurite guidance by microtopographical substrate features. J Biomed Mater Res A. 2016;104(8):2037–48. doi: 10.1002/jbm.a.35738 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ooashi N, Futatsugi A, Yoshihara F, Mikoshiba K, Kamiguchi H. Cell adhesion molecules regulate Ca2+-mediated steering of growth cones via cyclic AMP and ryanodine receptor type 3. Journal of Cell Biology. 2005;170(7):1159–67. doi: 10.1083/jcb.200503157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lyons WE, George EB, Dawson TM, Steiner JP, Snyder SH. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci U S A. 1994;91(8):3191–5. doi: 10.1073/pnas.91.8.3191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Welshhans K, Rehder V. Nitric oxide regulates growth cone filopodial dynamics via ryanodine receptor-mediated calcium release. European Journal of Neuroscience. 2007;26(6):1537–47. doi: 10.1111/j.1460-9568.2007.05768.x [DOI] [PubMed] [Google Scholar]
  • 21.Keilhoff G, Pinkernelle J, Fansa H. The Ryanodine receptor stabilizer S107 fails to support motor neuronal neuritogenesis in vitro. Tissue and Cell. 2021;73:101625. doi: 10.1016/j.tice.2021.101625 [DOI] [PubMed] [Google Scholar]
  • 22.Kim Yu S, Chu Y, Han L, Li M, Li Z, LaVinka Pamela C, et al. Central Terminal Sensitization of TRPV1 by Descending Serotonergic Facilitation Modulates Chronic Pain. Neuron. 2014;81(4):873–87. doi: 10.1016/j.neuron.2013.12.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Tuft BW, Li S, Xu L, Clarke JC, White SP, Guymon BA, et al. Photopolymerized microfeatures for directed spiral ganglion neurite and Schwann cell growth. Biomaterials. 2013;34(1):42–54. doi: 10.1016/j.biomaterials.2012.09.053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Xu L, Seline AE, Leigh B, Ramirez M, Guymon CA, Hansen MR. Photopolymerized Microfeatures Guide Adult Spiral Ganglion and Dorsal Root Ganglion Neurite Growth. Otol Neurotol. 2018;39(1):119–26. doi: 10.1097/MAO.0000000000001622 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Tuft BW, Xu L, White SP, Seline AE, Erwood AM, Hansen MR, et al. Neural pathfinding on uni- and multidirectional photopolymerized micropatterns. ACS Appl Mater Interfaces. 2014;6(14):11265–76. doi: 10.1021/am501622a [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Clarke JC, Tuft BW, Clinger JD, Levine R, Figueroa LS, Guymon CA, et al. Micropatterned methacrylate polymers direct spiral ganglion neurite and Schwann cell growth. Hear Res. 2011;278(1–2):96–105. doi: 10.1016/j.heares.2011.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Leigh BL, Truong K, Bartholomew R, Ramirez M, Hansen MR, Guymon CA. Tuning Surface and Topographical Features to Investigate Competitive Guidance of Spiral Ganglion Neurons. ACS Applied Materials & Interfaces. 2017;9(37):31488–96. doi: 10.1021/acsami.7b09258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Truong K, Leigh B, Vecchi JT, Bartholomew R, Xu L, Guymon CA, et al. Interaction of micropatterned topographical and biochemical cues to direct neurite growth from spiral ganglion neurons. Hear Res. 2021;409:108315. doi: 10.1016/j.heares.2021.108315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Brors D, Bodmer D, Pak K, Aletsee C, Schäfers M, Dazert S, et al. EphA4 provides repulsive signals to developing cochlear ganglion neurites mediated through ephrin-B2 and -B3. Journal of Comparative Neurology. 2003;462(1):90–100. doi: 10.1002/cne.10707 [DOI] [PubMed] [Google Scholar]
  • 30.Coate Thomas M, Raft S, Zhao X, Ryan Aimee K, Crenshaw EB, Kelley Matthew W. Otic Mesenchyme Cells Regulate Spiral Ganglion Axon Fasciculation through a Pou3f4/EphA4 Signaling Pathway. Neuron. 2012;73(1):49–63. doi: 10.1016/j.neuron.2011.10.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Defourny J, Poirrier A-L, Lallemend F, Mateo Sánchez S, Neef J, Vanderhaeghen P, et al. Ephrin-A5/EphA4 signalling controls specific afferent targeting to cochlear hair cells. Nature Communications. 2013;4(1):1438. doi: 10.1038/ncomms2445 [DOI] [PubMed] [Google Scholar]
  • 32.Tuft BW, Xu L, Leigh B, Lee D, Guymon CA, Hansen MR. Photopolymerized micropatterns with high feature frequencies overcome chemorepulsive borders to direct neurite growth. J Tissue Eng Regen Med. 2018;12(3):e1392–e403. doi: 10.1002/term.2527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Vecchi JT, Mullan S, Lopez JA, Hansen MR, Sonka M, Lee A. NeuriteNet: A convolutional neural network for assessing morphological parameters of neurite growth. J Neurosci Methods. 2021;363:109349. doi: 10.1016/j.jneumeth.2021.109349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hur E-M, Liu C-M, Jiao Z, Xu W-L, Zhou F-Q. PI3K–GSK3 signalling regulates mammalian axon regeneration by inducing the expression of Smad1. Nature communications. 2013;4(1):1–14. doi: 10.1038/ncomms3690 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hegarty JL, Kay AR, Green SH. Trophic support of cultured spiral ganglion neurons by depolarization exceeds and is additive with that by neurotrophins or cAMP and requires elevation of [Ca2+]i within a set range. J Neurosci. 1997;17(6):1959–70. doi: 10.1523/JNEUROSCI.17-06-01959.1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gafni J, Munsch JA, Lam TH, Catlin MC, Costa LG, Molinski TF, et al. Xestospongins: Potent Membrane Permeable Blockers of the Inositol 1,4,5-Trisphosphate Receptor. Neuron. 1997;19(3):723–33. doi: 10.1016/s0896-6273(00)80384-0 [DOI] [PubMed] [Google Scholar]
  • 37.Kim YS, Anderson M, Park K, Zheng Q, Agarwal A, Gong C, et al. Coupled Activation of Primary Sensory Neurons Contributes to Chronic Pain. Neuron. 2016;91(5):1085–96. doi: 10.1016/j.neuron.2016.07.044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Cheng EL, Leigh B, Guymon CA, Hansen MR. Quantifying Spiral Ganglion Neurite and Schwann Behavior on Micropatterned Polymer Substrates. Methods Mol Biol. 2016;1427:305–18. doi: 10.1007/978-1-4939-3615-1_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, Unser M. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A. 2004;58(2):167–76. doi: 10.1002/cyto.a.20022 [DOI] [PubMed] [Google Scholar]
  • 40.Vecchi JT, Rhomberg M, Guymon CA, Hansen MR. The geometry of photopolymerized topography influences neurite pathfinding by directing growth cone morphology and migration. Journal of Neural Engineering. 2024;21(2):026027. doi: 10.1088/1741-2552/ad38dc [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Li CY, Mittal R, Bergman J, Mittal J, Eshraghi AA. Recent advancements toward gapless neural-electrode interface post-cochlear implantation. Neural Regen Res. 2021;16(9):1805–6. doi: 10.4103/1673-5374.306085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wille I, Harre J, Oehmichen S, Lindemann M, Menzel H, Ehlert N, et al. Development of Neuronal Guidance Fibers for Stimulating Electrodes: Basic Construction and Delivery of a Growth Factor. Frontiers in Bioengineering and Biotechnology. 2022;10. doi: 10.3389/fbioe.2022.776890 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Frick C, Müller M, Wank U, Tropitzsch A, Kramer B, Senn P, et al. Biofunctionalized peptide-based hydrogels provide permissive scaffolds to attract neurite outgrowth from spiral ganglion neurons. Colloids and Surfaces B: Biointerfaces. 2017;149:105–14. doi: 10.1016/j.colsurfb.2016.10.003 [DOI] [PubMed] [Google Scholar]
  • 44.Li H, Edin F, Hayashi H, Gudjonsson O, Danckwardt-Lillieström N, Engqvist H, et al. Guided growth of auditory neurons: Bioactive particles towards gapless neural–electrode interface. Biomaterials. 2017;122:1–9. doi: 10.1016/j.biomaterials.2016.12.020 [DOI] [PubMed] [Google Scholar]
  • 45.Cai Y, Edin F, Jin Z, Alexsson A, Gudjonsson O, Liu W, et al. Strategy towards independent electrical stimulation from cochlear implants: Guided auditory neuron growth on topographically modified nanocrystalline diamond. Acta Biomaterialia. 2016;31:211–20. doi: 10.1016/j.actbio.2015.11.021 [DOI] [PubMed] [Google Scholar]
  • 46.Evans AR, Euteneuer S, Chavez E, Mullen LM, Hui EE, Bhatia SN, et al. Laminin and fibronectin modulate inner ear spiral ganglion neurite outgrowth in an in vitro alternate choice assay. Developmental neurobiology. 2007;67(13):1721–30. doi: 10.1002/dneu.20540 [DOI] [PubMed] [Google Scholar]
  • 47.Hackelberg S, Tuck SJ, He L, Rastogi A, White C, Liu L, et al. Nanofibrous scaffolds for the guidance of stem cell-derived neurons for auditory nerve regeneration. PLoS One. 2017;12(7):e0180427. doi: 10.1371/journal.pone.0180427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Liu F, Xu J, Wu L, Zheng T, Han Q, Liang Y, et al. The Influence of the Surface Topographical Cues of Biomaterials on Nerve Cells in Peripheral Nerve Regeneration: A Review. Stem Cells Int. 2021;2021:8124444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Jeon EJ, Xu N, Xu L, Hansen MR. Influence of central glia on spiral ganglion neuron neurite growth. Neuroscience. 2011;177:321–34. doi: 10.1016/j.neuroscience.2011.01.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Tojima T, Itofusa R, Kamiguchi H. Steering neuronal growth cones by shifting the imbalance between exocytosis and endocytosis. J Neurosci. 2014;34(21):7165–78. doi: 10.1523/JNEUROSCI.5261-13.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Hong K, Nishiyama M, Henley J, Tessier-Lavigne M, Poo M. Calcium signalling in the guidance of nerve growth by netrin-1. Nature. 2000;403(6765):93–8. doi: 10.1038/47507 [DOI] [PubMed] [Google Scholar]
  • 52.Gomez TM, Zheng JQ. The molecular basis for calcium-dependent axon pathfinding. Nature Reviews Neuroscience. 2006;7(2):115–25. doi: 10.1038/nrn1844 [DOI] [PubMed] [Google Scholar]
  • 53.Song Y, Li D, Farrelly O, Miles L, Li F, Kim SE, et al. The Mechanosensitive Ion Channel Piezo Inhibits Axon Regeneration. Neuron. 2019;102(2):373–89.e6. doi: 10.1016/j.neuron.2019.01.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Miles L, Powell J, Kozak C, Song Y. Mechanosensitive Ion Channels, Axonal Growth, and Regeneration. Neuroscientist. 2023;29(4):421–44. doi: 10.1177/10738584221088575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Shamah SM, Lin MZ, Goldberg JL, Estrach S, Sahin M, Hu L, et al. EphA Receptors Regulate Growth Cone Dynamics through the Novel Guanine Nucleotide Exchange Factor Ephexin. Cell. 2001;105(2):233–44. doi: 10.1016/s0092-8674(01)00314-2 [DOI] [PubMed] [Google Scholar]
  • 56.Baudet S, Bécret J, Nicol X. Approaches to Manipulate Ephrin-A:EphA Forward Signaling Pathway. Pharmaceuticals. 2020;13(7):140. doi: 10.3390/ph13070140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Gomez TM, Robles E, Poo M-m, Spitzer NC. Filopodial Calcium Transients Promote Substrate-Dependent Growth Cone Turning. Science. 2001;291(5510):1983–7. [DOI] [PubMed] [Google Scholar]
  • 58.Wolf AM, Lyuksyutova AI, Fenstermaker AG, Shafer B, Lo CG, Zou Y. Phosphatidylinositol-3-kinase-atypical protein kinase C signaling is required for Wnt attraction and anterior-posterior axon guidance. J Neurosci. 2008;28(13):3456–67. doi: 10.1523/JNEUROSCI.0029-08.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kang DS, Yang YR, Lee C, Park B, Park KI, Seo JK, et al. Netrin-1/DCC-mediated PLCγ1 activation is required for axon guidance and brain structure development. EMBO Rep. 2018;19(11). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Sutherland DJ, Goodhill GJ. The interdependent roles of Ca2+ and cAMP in axon guidance. Developmental Neurobiology. 2015;75(4):402–10. doi: 10.1002/dneu.22144 [DOI] [PubMed] [Google Scholar]
  • 61.Jones NP, Katan M. Role of phospholipase Cgamma1 in cell spreading requires association with a beta-Pix/GIT1-containing complex, leading to activation of Cdc42 and Rac1. Mol Cell Biol. 2007;27(16):5790–805. doi: 10.1128/MCB.00778-07 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Sujeong Jang

1 May 2024

PONE-D-24-12078Inositol trisphosphate and ryanodine receptor signaling distinctly regulate neurite pathfinding in response to engineered micropatterned surfacesPLOS ONE

Dear Dr. Vecchi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 15 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sujeong Jang

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information regarding the experiments involving animals and ensure you have included details on (1) methods of sacrifice, (2) methods of anesthesia and/or analgesia, and (3) efforts to alleviate suffering.

3. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

4. Thank you for stating the following financial disclosure: 

   "MH and AG: NIH-NIDCD R01-DC012578

JV: NIH-NIDCD F31-DC020371, and University of Iowa: NIGMS T32-GM007337" 

  

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. We note that your Data Availability Statement is currently as follows: "All relevant data are within the manuscript and its Supporting Information files."

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

Additional Editor Comments:

Thank you for submitting your study on PLOS ONE.

This study presents a comprehensive investigation into the role of IP3 and RyR signaling in neurite pathfinding of sensory neurons in response to biophysical cues in vitro. We deeply reviewed with 2 other reviewers, and decided for major revision.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Results section – make findings clearer and more concise.

Line 21: do you need a – after Micro-? This recurs throughout the paper. Consider removing – on the first word.

-This is repeated at other places in the paper

Line 54: “into close proximity to stimulating” – difficult to read may want to change “to” to

Successfully shows that disrupting Ca signaling alters neurite growth direction.

Line 446: Is this 20% reduction significant?

Good paper highlighting the importance in Ca pathways in direction of neurite growth.

Excellent Figures.

Reviewer #2: This study presents a comprehensive investigation into the role of IP3 and RyR signaling in neurite pathfinding of sensory neurons in response to biophysical cues in vitro. The manuscript is well-written, the conclusions are appropriate and supported by the data, and the findings are likely to be of interest to a wide audience as neurite growth is important for many biological processes and applications. The use of different combinations of micropatterned geometries and biochemical cues illustrates nicely the different functions of IP3 and RyR signaling in neurite pathfinding. The main drawback of this manuscript is that the effect sizes appear to be small and very specific to the measurements chosen, bringing into question the biological significance of the findings. Some clarification on the specific points below will help to address this concern.

1. The introduction provides a good overview of the background into the field and existing technologies for the study of biochemical and biophysical cues for neurite outgrowth. The motivation for the study is generally clear although the authors could revise the paragraph on page 3 beginning on line 81 to more clearly state where the knowledge gap is within Ca2+ signaling and the RyR/IP3 pathways that this study addresses. Mainly, to answer the question of if is it known that they are all involved in neurite guidance, but it is unknown which type of environmental signal they respond to?

2. Page 3, line 60: typo “In this, the growth cone plays a pivotal role in pathfinding responding to diverse…”

3. The authors should provide more rationale for the three micropatterned geometries chosen for this study. Some explanation is peppered through the results and discussion but clearer statements upfront would enhance the understanding of the findings

4. Since almost all experiments involve the use of ryanodine and xestospongin C the authors should include more explanation of how the concentrations were chosen and confirmed to inhibit RyR/IP3 signaling? Is inhibition with these drugs complete? Does administration of the drug affect cell viability?

5. In addition to the number of technical replicates (e.g., growth cones, etc), the biological sample size should be stated in the figure legends – i.e., the number of animals neurons were derived from. Can the authors also comment on how the statistical tests were conducted, i.e., which sample size was used for the analysis?

6. Did the authors confirm that neuron viability is unaffected by culture on micropatterned substrates?

7. Page 6, line 197: please revise sentence so it is clear which drugs are added to cells in these experiments

8. Page 6, line 201 and page 6, line 213: how were growth cones identified and ROIs selected? NF200 expression is not specific to the growth cone

9. Page 9, line 326: what is the biological relevance or significance of changes in growth cone morphology and orientation, and the relation to Ca2+ signaling?

10. Since the analysis method appears to be unique to this manuscript and is somewhat complex to understand with text alone, Section 2.10, 2.11, and 2.12 may benefit from a supplementary figure illustrating the explanations of how neurite turning was classified and scored

11. Page 10, line 369: The authors should provide references for the statement “EphA4-Fc serves as a chemorepulsive cue to SGN neurite growth…”

12. The authors should consider also testing DRGNs in the more complex zigzag topographically patterned substrates to compare to the SGNs. It would be interesting to know if different types of sensory neurons responded differently to drug treatments

13. Can the authors comment on the effect of inhibiting RyR and IP3 together? Would there be an additive inhibitory effect on neurite growth? If those experiments were performed, please include in the manuscript, or if not authors can comment on the hypothesized effect

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Reid Bartholomew

Reviewer #2: Yes: Samantha Payne

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Sujeong Jang

26 Jun 2024

Inositol trisphosphate and ryanodine receptor signaling distinctly regulate neurite pathfinding in response to engineered micropatterned surfaces

PONE-D-24-12078R1

Dear Dr. Hansen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sujeong Jang

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed adequately and I agree that it is suitable for publication at this time.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Samantha Payne

Reviewer #3: No

**********

Acceptance letter

Sujeong Jang

24 Jul 2024

PONE-D-24-12078R1

PLOS ONE

Dear Dr. Hansen,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sujeong Jang

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Methods to measure neurite behavior in response to angled topographical microfeature.

    (A) Schematic demonstrating the derivation of percent of neurite length in topographical microfeature. (B) Schematic demonstrating calculation of turns. Neurite is segmented in to 10 μm segments and the angle relative to the horizontal calculated for each segment. The MATLAB program counts a turn when 3 consecutive segments vary by >10°. (C) Schematic demonstrating the measurement of the length a neurite remains in topographical microfeature. Scale bars = 50 μm.

    (TIF)

    pone.0308389.s001.tif (835KB, tif)
    S2 Fig. Inhibiting Ca2+ release from internal has no effect on SGN neurite length on chemo-permissive laminin stripes.

    Total neurite length of SGNs cultured in the respective conditions. Kruskal-Wallis testing shows no effect of treatment on SGN neurite growth. Graph shows median Alignment Index +/- 95% CI. n = 38, 59, 52, 36 neurons.

    (TIF)

    pone.0308389.s002.tif (95.8KB, tif)
    S3 Fig. Inhibiting Ca2+ release from internal has no effect on SGN neurite length on chemo-repulsive EphA4 stripes.

    Total neurite length of SGNs cultured in the respective conditions. Kruskal-Wallis testing shows no effect of treatment on SGN neurite growth. Graph shows median Alignment Index +/- 95% CI. n = 38, 33, 33, 39 neurons.

    (TIF)

    pone.0308389.s003.tif (96.1KB, tif)
    S4 Fig. Inhibiting RyR or IP3 signaling has no effect on neurite length on a zig zag Micropatterned Substrate.

    Total neurite length of SGNs cultured in the respective conditions. Kruskal-Wallis testing shows no effect of treatment on SGN neurite growth. Graph shows median Alignment Index +/- 95% CI. n = 53, 100, 109, 89 neurons.

    (TIF)

    pone.0308389.s004.tif (126.4KB, tif)
    S5 Fig. Inhibiting Ca2+ release from internal stores impairs guidance to angled biophysical microfeatures.

    (A-C). Representative images of fixed SGNs growing in response to topographical microfeature turn challenges either untreated (A), treated with 100μM ryanodine (B), or 2μM xestospongin C (C). (D) Length neurite remains in topographical microfeature once encountering it. Two-way ANOVA on ranks suggests that both treatments impair the ability of SGNs to follow the topographical microfeature turn challenges and length followed increases with more gradual turns. Data are 95% confidence interval box and whisker. n = 29, 645, 355, 348 neurite encounters. Scale bar = 100 μm.

    (TIF)

    pone.0308389.s005.tif (222.2KB, tif)
    S1 Data. Raw data corresponding to Figs 5, 6D and S4.

    (XLSX)

    pone.0308389.s006.xlsx (33.8KB, xlsx)
    S1 File. Additional description of statistics and data visualization.

    (PDF)

    pone.0308389.s007.pdf (122.2KB, pdf)
    Attachment

    Submitted filename: PLOS ONE Response.pdf

    pone.0308389.s008.pdf (120.9KB, pdf)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES